Cancer cachexia is a complex syndrome characterized by severe, involuntary weight loss, muscle wasting, and a significant decline in appetite and physical function, commonly seen in patients with advanced cancer. Unlike general weight loss, cancer cachexia involves the loss of both fat and muscle mass and is not easily reversible with nutritional support alone.

Cancer Cachexia Market Overview
Cancer Cachexia Market is expected to reach a CAGR of 6.8% By 2031

The pathogenicity of cancer cachexia is multifactorial, resulting from a complex interaction between tumor and host factors. The signs and symptoms of cachexia serve as important prognostic indicators in cancer patients. Medications for cancer cachexia are used to treat or alleviate the condition, addressing the underlying factors contributing to its development.

Request for free sample:https://www.datamintelligence.com/download-sample/cancer-cachexia-market

Cancer Cachexia Market Trends
The growth of the global cancer cachexia market is fueled by the increasing prevalence of serious health conditions, such as cancer, and the rising incidence of cachexia among these patients. This growth is further supported by heightened awareness of the availability and convenience of novel therapeutic drugs for treating cancer cachexia.

Major pharmaceutical companies are focusing their research and development efforts on creating highly effective new medications for the treatment of cancer cachexia. Consequently, the number of drugs in the pipeline, pending approval, and commercial launch has risen. According to data from clinicaltrials.gov, as of February 7, 2022, 141 studies have either been completed or are currently underway to discover medications for treating cancer cachexia.

Get your customized report @https://www.datamintelligence.com/customize/cancer-cachexia-market

Cancer Cachexia Market is segmented
By Therapeutics: Corticosteroids, Cannabinoids (Dronabinol), Anabolic Steriods, Cytokine Inhibitors, Others
By Mechanism: Appetite Stimulators, Weight Loss Stabilizers, Others
By Distribution Channel: Hospital Stores, Retail Pharmacy Stores, Online Pharmacy
By Region: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa

Cancer Cachexia Companies
• Aeterna Zentaris
• Aphios Corporation
• Bristol-Myers Squibb Company
• Pfizer Inc.
• Helsinn Group
• Merck KGaA
• Artelo Biosciences Inc.
• NGM Biopharmaceuticals
• Aveo Oncology
• Aavogen Inc.

Related Reports
Europe Cancer Cachexia Market
Cancer Vaccines Market
Peptide Cancer Vaccine Market

Contact Us:
Company Name: DataM Intelligence
Email: [email protected]
Contact Person: Sai. K
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence:
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. At DataM Intelligence, we leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across